Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.

× No keyword cloud information.

38 in total

Review 1. Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?

Authors: Leopold Sellner; Sascha Dietrich; Peter Dreger; Hanno Glimm; Thorsten Zenz
Journal: Curr Hematol Malig Rep Date: 2012-03 Impact factor: 3.952

Review 2. Targeted therapy for chronic lymphocytic leukemia.

Authors: Alfonso Quintás-Cardama; Susan O'Brien
Journal: Target Oncol Date: 2009-01-27 Impact factor: 4.493

Review 3. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia.

Authors: Russell A Higgins; Shelly R Gunn; Ryan S Robetorye
Journal: Mol Diagn Ther Date: 2008 Impact factor: 4.074

Review 4. How I treat CLL up front.

Authors: John G Gribben
Journal: Blood Date: 2009-10-22 Impact factor: 22.113

Review 5. Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.

Authors: Clive S Zent; Neil E Kay
Journal: Leuk Lymphoma Date: 2011-06-08

6. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

Authors: Andrew Mone; Shannon Puhalla; Susan Whitman; Robert A Baiocchi; Julio Cruz; Tamara Vukosavljevic; Amy Banks; Charles F Eisenbeis; John C Byrd; Michael A Caligiuri; Pierluigi Porcu
Journal: Blood Date: 2005-08-02 Impact factor: 22.113

Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.

Review 1. Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?

Review 2. Targeted therapy for chronic lymphocytic leukemia.

Review 3. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia.

Review 4. How I treat CLL up front.

Review 5. Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.

6. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

Review 7. Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.

Review 8. Antibody therapy for chronic lymphocytic leukemia.

Review 9. Management of Chronic Lymphocytic Leukemia in the Elderly.

10. Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL).